Literature DB >> 15887107

Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils.

Gabriele Rieder1, Juanita L Merchant, Rainer Haas.   

Abstract

BACKGROUND & AIMS: Epidemiological studies suggest that atrophic corpus-dominant gastritis is an increased risk factor for gastric carcinogenesis. The role of the Helicobacter pylori type IV secretion system (T4SS) for pathogenesis in the Mongolian gerbil model was explored.
METHODS: Mongolian gerbils were infected for 32 weeks either with H. pylori type I strain B128 or with isogenic mutant strain B128delta cytotoxin-associated gene (cagY) or B128delta cagA , defective in T4SS or in the production of its effector protein CagA, respectively. Quantitative H. pylori reisolation was performed from the gastric antrum and corpus separately, cytokines were measured by quantitative reverse-transcription polymerase chain reaction, and gastric pH and hormones were determined.
RESULTS: B128-infected gerbils harbored high numbers of bacteria in the gastric antrum and corpus, whereas B128delta cagY and B128delta cagA colonized the antrum more densely than the corpus. All infected animals showed a strong antral inflammation and epithelial cell proliferation. B128-infected, rather than mutant-infected, gerbils presented a severe transmural inflammation with huge lymph aggregates, increased proliferation, significant atrophy, and mucous gland metaplasia in the corpus. Plasma gastrin levels and gastric pH values were significantly increased only in B128-infected gerbils. In all infected animals, the expression of the proinflammatory cytokines interleukin 1beta, interferon gamma, and growth-regulated protein was considerably increased in the antrum, but only in wild type-infected animals was an increase seen in the corpus mucosa.
CONCLUSIONS: The presence of an intact T4SS allows H. pylori to colonize the gastric corpus. This results in atrophic corpus-dominant gastritis, a severe precancerous condition, thus highlighting T4SS and CagA as major risk factors for gastric cancer development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887107     DOI: 10.1053/j.gastro.2005.02.064

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  80 in total

1.  Role of Helicobacter pylori CagL in modulating gastrin expression.

Authors:  Timothy L Cover
Journal:  Gut       Date:  2012-03-09       Impact factor: 23.059

2.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 3.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

4.  The Mongolian Gerbil: A Robust Model of Helicobacter pylori-Induced Gastric Inflammation and Cancer.

Authors:  Jennifer M Noto; Judith Romero-Gallo; M Blanca Piazuelo; Richard M Peek
Journal:  Methods Mol Biol       Date:  2016

5.  Multistep activation of the Helicobacter pylori effector CagA.

Authors:  Anne Müller
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

6.  Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration.

Authors:  Amber C Beckett; M Blanca Piazuelo; Jennifer M Noto; Richard M Peek; M Kay Washington; Holly M Scott Algood; Timothy L Cover
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

7.  CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.

Authors:  Roberto M Barrozo; Lori M Hansen; Anna M Lam; Emma C Skoog; Miriam E Martin; Lucy P Cai; Yong Lin; Andreas Latoscha; Sebastian Suerbaum; Don R Canfield; Jay V Solnick
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

Review 8.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

9.  Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.

Authors:  Yinfei Yin; Anna M Grabowska; Philip A Clarke; Elisabeth Whelband; Karen Robinson; Richard H Argent; Amanda Tobias; Rajendra Kumari; John C Atherton; Susan A Watson
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

10.  Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.

Authors:  Amanda Oldani; Mireille Cormont; Veronique Hofman; Valentina Chiozzi; Olivier Oregioni; Alexandra Canonici; Anna Sciullo; Patrizia Sommi; Alessia Fabbri; Vittorio Ricci; Patrice Boquet
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.